台股 » 個股 » 杏國 » 籌碼相關 » 券商分點績效

杏國

(4192)
  • 股價
    48.20
  • 漲跌
    ▲0.75
  • 漲幅
    +1.58%
  • 成交量
    25
  • 產業
    上櫃 生技醫療類股
  • 119人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
杏國 (4192)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/26     後一日»

券商獲利排行 - 2024/04/26

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  8.19%2580258-5906052.552.552.548.2
  8.10%2550255-6006052.5052.548.2
  8.19%86086-2002052.5052.548.2
  4.37%22022-1001050.4050.448.2
  8.19%21.5021.5-40552.552.452.548.2
  7.27%18.9018.9-5055205248.2
  8.19%17.2017.2-40452.5052.548.2
  8.19%17.2017.2-40452.5052.548.2
  6.11%15.9312.9-32552.15152.548.2
  7.40%15.4015.4-40452.1052.148.2
  8.19%12.9012.9-30352.5052.548.2
  8.19%12.9012.9-30352.5052.548.2
  8.19%12.9012.9-30352.5052.548.2
  6.18%12.7012.7-40451.4051.448.2
  6.04%9.309.3-30351.3051.348.2
  8.19%8.608.6-20252.5052.548.2
  8.19%8.608.6-20252.5052.548.2
  8.19%8.608.6-20252.5052.548.2
  8.19%8.608.6-20252.5052.548.2
  8.19%8.608.6-20252.5052.548.2
  8.19%8.608.6-20252.5052.548.2
  8.19%8.608.6-20252.5052.548.2
  8.17%8.608.6-20252.5052.548.2
  5.49%8.408.4-3035105148.2
  7.13%7.407.4-20251.9051.948.2
  6.86%7.107.1-20251.8051.848.2
  8.19%4.304.3-10152.5052.548.2
  8.19%4.304.3-10152.5052.548.2
  8.19%4.304.3-10152.5052.548.2
  8.19%4.304.3-10152.5052.548.2
  8.19%4.304.3-10152.5052.548.2
  8.19%4.304.3-10152.5052.548.2
  8.19%4.304.3-10152.5052.548.2
  8.19%4.304.3-10152.5052.548.2
  8.19%4.304.3-10152.5052.548.2
  8.19%4.304.3-10152.5052.548.2
  8.19%4.304.3-10152.5052.548.2
  8.19%4.304.3-10152.5052.548.2
  8.19%4.304.3-10152.5052.548.2
  8.19%4.304.3-10152.5052.548.2
  8.19%4.304.3-10152.5052.548.2
  8.19%4.304.3-10152.5052.548.2
  8.19%4.304.3-10152.5052.548.2
  8.19%4.304.3-10152.5052.548.2
  8.19%4.304.3-10152.5052.548.2
  8.19%4.304.3-10152.5052.548.2
  8.19%4.304.3-10152.5052.548.2
  8.19%4.304.3-10152.5052.548.2
  8.19%4.304.3-10152.5052.548.2
  8.19%4.304.3-10152.5052.548.2

券商虧損排行 - 2024/04/26

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -7.49%-148.40-148.43838052.152.1048.2
  -8.19%-68.80-68.81616052.552.5048.2
  -8.19%-64.50-64.51515052.552.5048.2
  -8.19%-430-431010052.552.5048.2
  -8.19%-38.70-38.799052.552.5048.2
  -8.19%-34.40-34.488052.552.5048.2
  -8.19%-34.40-34.488052.552.5048.2
  -8.19%-30.10-30.177052.552.5048.2
  -7.17%-30.10-30.178152.552.552.548.2
  -5.49%-25.8-1-24.869352.352.35248.2
  -8.19%-25.80-25.866052.552.5048.2
  -8.19%-25.80-25.866052.552.5048.2
  -8.19%-25.80-25.866052.552.5048.2
  -7.93%-24.90-24.966052.452.4048.2
  -8.19%-21.50-21.555052.552.5048.2
  -8.19%-21.50-21.555052.552.5048.2
  -8.19%-21.50-21.555052.552.5048.2
  -8.19%-21.50-21.555052.552.5048.2
  -8.19%-21.50-21.555052.552.5048.2
  -7.56%-19.70-19.755052.152.1048.2
  -7.66%-160-1644052.252.2048.2
  -8.19%-12.90-12.933052.552.5048.2
  -8.19%-12.90-12.923052.552.552.148.2
  -8.19%-12.90-12.933052.552.5048.2
  -7.84%-12.30-12.333052.352.3048.2
  -3.85%-9.60-9.655050.150.1048.2
  -8.19%-8.60-8.622052.552.5048.2
  -8.19%-8.60-8.622052.552.5048.2
  -8.19%-8.60-8.622052.552.5048.2
  -8.19%-8.60-8.622052.552.5048.2
  -8.19%-8.60-8.622052.552.5048.2
  -8.19%-8.60-8.622052.552.5048.2
  -8.19%-8.60-8.622052.552.5048.2
  -8.19%-8.60-8.622052.552.5048.2
  -8.02%-8.40-8.422052.452.4048.2
  -7.40%-7.70-7.722052.152.1048.2
  -7.13%-7.40-7.412051.951.952.348.2
  -2.63%-6.50-6.555049.549.5048.2
  -5.58%-5.8-1.5-4.31215252.55148.2
  -8.19%-4.30-4.311052.552.5048.2
  -4.10%-4.30-4.312152.552.552.548.2
  -4.10%-4.30-4.312152.552.552.548.2
  -8.19%-4.30-4.311052.552.5048.2
  -8.19%-4.30-4.311052.552.5048.2
  -8.19%-4.30-4.311052.552.5048.2
  -8.19%-4.30-4.311052.552.5048.2
  -8.19%-4.30-4.311052.552.5048.2
  -8.19%-4.30-4.311052.552.5048.2
  -8.19%-4.30-4.311052.552.5048.2
  -8.19%-4.30-4.311052.552.5048.2
杏國將在歐洲腫瘤內科學會亞洲年會 發表胰臟癌臨床結果UDN聯合新聞網-2022/09/25
杏國胰臟癌新藥三期試驗喊卡 待美FDA通知補件Anue鉅亨-2022/05/18
杏國 相關文章